Pharmaceutical composition comprising a glp-1 agonist and methionine
作者： Werner Mueller , Anette Brunner-Schwarz , Verena Siefke-Henzler
DOI:
关键词:
摘要: The invention relates to a liquid composition comprising GLP-1 agonist or/and pharmacologically tolerable salt thereof and optionally at least one pharmaceutically acceptable adjuvant. is characterised in that it contains methionine, as add-on therapy with metformin and/or long-acting insulins/insulin derivatives.
lens.org参考文章(769)
Roderike Pohl, Nandini Kashyap, Solomon S. Steiner, Insulin formulations for insulin release as a function of tissue glucose levels ,(2009)
Cindy Sage, Sage Associates, Summary for the Public ,(2007)
Klaus Joergensen, Magnesium containing insulin solution ,(1989)
Kamlesh Patel, Ronald T. Borchardt, Chemical Pathways of Peptide Degradation. II. Kinetics of Deamidation of an Asparaginyl Residue in a Model Hexapeptide Pharmaceutical Research. ,vol. 7, pp. 703- 711 ,(1990) , 10.1023/A:1015807303766
K. Geisen, H. Thurow, Stabilisation of dissolved proteins against denaturation at hydrophobie interfaces Diabetologia. ,vol. 27, pp. 212- 218 ,(1984) , 10.1007/BF00273809
Melvin T. Magliocco, Matthew C. Fleming, Radiation shield swivel mount ,(1988)
F. Sundby, Separation and Characterization of Acid-induced Insulin Transformation Products by Paper Electrophoresis in 7 m Urea Journal of Biological Chemistry. ,vol. 237, pp. 3406- 3411 ,(1962) , 10.1016/S0021-9258(19)70830-8
Richard L Jackson, Protamine-insulin product ,(1973)
Ralph Farella, Leonard Epifano, Carl Collica, Radiation guard for X-ray table ,(1974)